Tirzepatide Next-generation dual-receptor therapy Activates both GLP-1 and GIP receptors delivering superior appetite control and stronger metabolic outcomes than single-pathway medications
TB-500, a synthetic analogue of Thymosin Beta-4, interacts with G-actin through the conserved LKKTET motif, influencing actin-binding dynamics, cytoskeletal organization, and actin-associated signaling systems
Characterising the muscle anabolic potential of dairy, meat and plant-based protein sources in older adults
The medications have different active ingredients but similar side effects
Therefore, treatment should follow assessment and structured dosing
Depending on the company, the prescriber might speak to a patient directly via video chat (rare) or just write a prescription based on a form that a patient has filled out (more common)